Phase 1/2 Trial of Avelumab Combined with Utomilumab (4-1BB Agonist), PF-04518600 (OX40 Agonist), or Radiotherapy in Patients with Advanced Gynecologic Malignancies
CANCER(2024)
Key words
cervical cancer,endometrial cancer,immune checkpoint blockade,immunotherapy,ovarian cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined